📰 Brian Lenz News
Brian Lenz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Brian Lenz. Real-time updates on events, politics, business and more.
May 23, 2024
Whats New on Max This June
February 29, 2024
ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2023 Earnings Call Transcript February 28, 2024 ADMA Biologics, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $0.02. ADMA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. And welcome […]
February 28, 2024
By Stephen Nakrosis ADMA Biologics said Brian Lenz, the company's EVP, chief financial officer and general manager, ADMA BioCenters, will transition from...
January 26, 2024
Honoring the final home meet of the Lindenwood women's swim & dive meet, which will be cut at the conclusion of the season.
November 13, 2023
ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) – Cantor Fitzgerald raised their FY2024 EPS estimates for shares of ADMA Biologics in a note issued to investors on Thursday, November 9th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will post earnings per share of $0.18 for the year, up from their previous […]
November 6, 2023
ADMA Biologics (NASDAQ:ADMA – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Wednesday, November 8th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link. ADMA […]
September 13, 2023
StockNews.com downgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a hold rating to a sell rating in a report issued on Sunday morning. Several other analysts have also recently commented on ADMA. TheStreet upgraded ADMA Biologics from a d rating to a c- rating in a report on Friday, May 19th. Cantor Fitzgerald […]
September 6, 2023
StockNews.com upgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a sell rating to a hold rating in a report published on Saturday morning. Several other analysts have also recently commented on the company. Cantor Fitzgerald raised their target price on ADMA Biologics from $5.00 to $6.00 and gave the company an overweight rating […]
September 6, 2023
The weather is crap. That’s the good way to put it.
September 3, 2023
Thousands of gamers are in Grand Rapids this weekend for the ninth annual GrandCon Gaming Convention at DeVos Place.